ARTICLE | Company News
Avita, U.S. Department of Health and Human Services dermatology, gene/cell therapy news
July 18, 2016 7:00 AM UTC
HHS’s Biomedical Advanced Research and Development Authority (BARDA) awarded Avita an $8 million extension to support U.S. approval and launch of Avita’s ReCell device. Last September, BARDA awarded ...